Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism
Author:
- 1 March 2006
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 109 (3) , 339-365
Abstract
No abstract availableKeywords
This publication has 198 references indexed in Scilit:
- Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns StudyKidney International, 2005
- In Vitro Studies with the Calcimimetic, Cinacalcet HCl, on Normal Human Adult Osteoblastic and Osteoclastic CellsCritical Reviews™ in Eukaryotic Gene Expression, 2003
- Functional GABAB receptors expressed in cultured calvarial osteoblastsBiochemical and Biophysical Research Communications, 2002
- Parathyroid Expression of Calcium-Sensing Receptor Protein and in Vivo Parathyroid Hormone-Ca2+ Set-Point in Patients with Primary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2000
- Tumor-Specific Decreased Expression of Calcium Sensing Receptor Messenger Ribonucleic Acid in Sporadic Primary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 1997
- Loss of Calcium Responsiveness in Cultured Bovine Parathyroid Cells Is Associated with Decreased Calcium Receptor ExpressionBiochemical and Biophysical Research Communications, 1995
- Calcium receptor messenger ribonucleic acid levels in the parathyroid glands and kidney of vitamin D-deficient rats are not regulated by plasma calcium or 1,25-dihydroxyvitamin D3Endocrinology, 1995
- Reduced Binding of [3H]l,25-Dihydroxyvitamin D3in the Parathyroid Glands of Patients with Renal FailureNew England Journal of Medicine, 1987
- The Influence of Hypermagnesemia on Serum Calcium and Parathyroid Hormone Levels in Human SubjectsNew England Journal of Medicine, 1984
- Changes in Histologic and Biochemical Indexes of Bone Turnover after Bilateral Nephrectomy in Patients on HemodialysisNew England Journal of Medicine, 1977